Chronic leukocytosis associated with clozapine treatment

Clinical Schizophrenia and Related Psychoses

Volumn 4, Issue 2, 2010, Pages 141-144

  Sopko, Michael A ^a   Caley, Charles F ^b  

^a TOURO COLLEGE   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Clozapine; Leukocytosis; Side effects

Indexed keywords

ANTIBIOTIC AGENT; BENZATROPINE; CLOMIPRAMINE; CLONAZEPAM; CLOZAPINE; DISULFIRAM; DONEPEZIL; ESOMEPRAZOLE; FLUOXETINE; HALOPERIDOL; LANSOPRAZOLE; MYOGLOBIN; TRAZODONE; ZOLPIDEM;

ADULT; ARTHRALGIA; ARTICLE; CASE REPORT; CHILL; CHRONIC DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; FEVER; FOLLOW UP; HEADACHE; HUMAN; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; MYALGIA; OBSESSIVE COMPULSIVE DISORDER; PARANOID SCHIZOPHRENIA; RHABDOMYOLYSIS; SINUS CONGESTION; TUBERCULOSIS; UPPER RESPIRATORY TRACT INFECTION;

ADULT; ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; HUMANS; LEUKOCYTE COUNT; LEUKOCYTOSIS; MALE; SCHIZOPHRENIA, PARANOID;

EID: 77953898189     PISSN: 19351232     EISSN: None     Source Type: Journal    
DOI: 10.3371/CSRP.4.2.6     Document Type: Article

References (13)

1. Clozaril (clozapine) [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corporation; May 2005.
2. Honigfeld G, Arellano F, Sethi J, Bianchini A, Schein J. Reducing clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry. J Clin Psychiatry 1998;59(Suppl 3):3-7. (Pubitemid 28196363)
3. Gerson SL. Clozapine--deciphering the risks. N Engl J Med 1993;329(3):204-205.
4. Pollmacher T, Fenzel T, Mullington J, Hinze-Selch D. The influence of clozapine treatment on plasma granulocyte colony-stimulating (G-CSF) levels. Pharmacopsychiatry 1997;30(4):118-121. (Pubitemid 27362079)
5. Alvir JM, Lieberman JA. Agranulocytosis: incidence and risk factors. J Clin Psychiatry 1994;55(Supp B):137-138.
6. Alvir JM, Lieberman JA, Safferman AZ. Do white-cell count spikes predict agranulocytosis in clozapine recipients? Psychopharmacol Bull 1995;31(2):311-314.
7. Deliliers GL. Blood dyscrasias in clozapine-treated patients in Italy. Haematologica 2000;85(3):233-237.
8. Hummer M, Kurz M, Barnas C, Saria A, Fleischhacker WW. Clozapine-induced transient white blood count disorders. J Clin Psychiatry 1994;55(10):429-432.
9. Trinidad ED, Potti A, Mehdi SA. Clozapine-induced blood dyscrasias. Haematologica 2000; 85(E-letters):E02.
10. Popli A, Pies R. Clozapine and leukocytosis. J Clin Psychopharmacol 1995;15(4):286-287.
11. Madhusoodanan S, Cuni L, Brenner R, Sajatovic M, Palekar N, Amanbekova D. Chronic leukocytosis associated with clozapine: a case series. J Clin Psychiatry 2007;68(3):484-488.
12. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30(2):239-245. (Pubitemid 12149145)
13. Nexium (esomeprazole) [package insert]. Wilmington, DE: AstraZeneca; April 2007.